Krause Irit, Davidovits Miriam, Tamary Hannah, Yutcis Maria, Dagan Amit
Institute of Nephrology, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel.
Department of Pediatrics C, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel.
Pediatr Transplant. 2016 Nov;20(7):958-962. doi: 10.1111/petr.12792. Epub 2016 Sep 12.
PTA and anemia of CKD share a similar pathogenesis. However, PTA may be disproportionate to the reduction in the GFR. Data relating to the mechanism of PTA are scarce. We evaluated the erythropoiesis parameters in pediatric kidney recipients compared to children with CKD. A total of 100 patients (54 post-kidney TX, 46 with CKD) were enrolled in the single-center cohort study. GFR was found to be significantly lower in the CKD group (49.7±22.4 vs 72.9±28.5 mL/min/1.73 m², P<.001); anemia was significantly more common in the TX patients (52% vs 41.3%, P<.001). Iron transferrin saturation and serum ferritin levels were lower in the CKD patients. In both groups, hemoglobin Z scores significantly correlated with GFR (R=.31, P=.07). This correlation was more prominent in the CKD group (R=.43, P=.008) compared to the TX group (R=.31, P=.04). Anemia was significantly more common in the TX patients than in the CKD patients despite a better GFR. The higher prevalence of anemia in the TX group could not be explained by an iron deficiency or reduced EPO production. We speculate that immunosuppressive therapy together with resistance to EPO may play a role in the pathogenesis of post-transplantation anemia.
慢性肾脏病(CKD)患者的纯红细胞再生障碍性贫血(PTA)与贫血具有相似的发病机制。然而,PTA可能与肾小球滤过率(GFR)的降低不成比例。关于PTA机制的数据很少。我们评估了小儿肾移植受者与CKD患儿相比的红细胞生成参数。在这项单中心队列研究中,共纳入了100例患者(54例肾移植术后患者,46例CKD患者)。发现CKD组的GFR显著更低(49.7±22.4对比72.9±28.5 mL/min/1.73 m²,P<0.001);移植患者中贫血明显更常见(52%对比41.3%,P<0.001)。CKD患者的铁转铁蛋白饱和度和血清铁蛋白水平更低。在两组中,血红蛋白Z评分均与GFR显著相关(R=0.31,P=0.07)。与移植组(R=0.31,P=0.04)相比,这种相关性在CKD组中更显著(R=0.43,P=0.008)。尽管移植患者的GFR更好,但贫血在移植患者中比CKD患者明显更常见。移植组中贫血的较高患病率不能用缺铁或促红细胞生成素(EPO)生成减少来解释。我们推测免疫抑制治疗以及对EPO的抵抗可能在移植后贫血的发病机制中起作用。